Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Mark Clapp

MFM · MGH

View

Dr. Kirat Sandhu

MFM · UH

View

Dr. Malavika Prabhu

MFM · MGH

View

Dr. Katherine Bligard

MFM · WUSTL

View

Dr. Ilina Pluym

MFM · UCLA

View

Dr. Andrew Rausch

MFM · UCMC

View

Dr. Karen Gibbins

MFM · OHSU Hospital

View

Dr. Susan Khalil

MIGS · ISMMS

View

Dr. Tori O’Daniel

OB Hospitalist · Laborie-MCH division, Senior Medical Director

View

Dr. Alissa Erogbogbo

OB Hospitalist · Washington Health System

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy.

    Oct 7, 2026DOI: 10.1093/cid/ciag422Journal ArticleCID

    Written by: L Madeline McCraryMegan R CurtisJeannie C KellyJessica Elrod-GallegosPatrick KojimaPatricia WernerJennifer L MullersmanTracey Habrock-BachMichael J DurkinLaura R Marks

    Find these authors on Roon

    MM

    Dr. Madeline McCrary

    General ID · WUSTL

    JK

    Dr. Jeannie Kelly

    MFM · WUSTL

    Summary

    Guidelines endorse antenatal hepatitis C virus treatment following shared decision making. No clinical trial or real-world data exist for glecaprevir-pibrentasvir (GLE/PIB). We report our experience with prenatal GLE/PIB in 14 patients. Ten patients completed treatment; all achieved virologic response by or at delivery, with no maternal or neonatal safety concerns.
    JKDr. Jeannie Kelly
    Leading Voice

    Dr. Jeannie Kelly

    Obstetrics & Gynecology (OBGYN) · Maternal Fetal Medicine (MFM)
    Washington University in St. Louis
    drjeanniekelly
    St. Louis, MO